J.Safra Asset Management »

Keros Therapeutics shares owned by J.Safra Asset Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by J.Safra Asset Management from 13F filings

Historical chart of J.Safra Asset Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by J.Safra Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by J.Safra Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $339 6 56.50

More positions owned by J.Safra Asset Management

Invesco Qqq Tr Unit Ser 1 Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Trust Etf Tr Unit (SPY)
Select Sector Spdr Trust The Technology Select Sector Spdr Fund Technology (XLK)
Select Sector Spdr Trust The Health Care Select Sector Spdr Fund Sbi Healthcare (XLV)
Select Sector Spdr Trust The Financial Select Sector Spdr Fund Financial (XLF)
Select Sector Spdr Trust The Communication Services Select Sector Spdr Fund Communication (XLC)
Ishares Russell 1000 Growth Etf Rus 1000 Grw Etf (IWF)
Select Sector Spdr Trust The Industrial Select Sector Spdr Fund Indl (XLI)
Spdr S&p Dividend Etf S&P Divid EFT (SDY)
Select Sector Spdr Trust The Utilities Select Sector Spdr Trust Sbi Int-utils (XLU)
Invesco Exchange Traded Fund Trust Invesco S&p 500 Equal Weight Etf S&p500 Eql Wgt (RSP)
Ishares Core S&p Small Cap Etf Core S&p Scp Etf (IJR)
Sector Spdr Trust Sbi Consumer Staples Sbi Cons Stpls (XLP)
Vaneck Etf Tr Vaneck Semiconductor Etf Semiconductr Etf (SMH)
Select Sector Spdr Trust Shs Ben Int Energy Energy (XLE)

View all positions for J.Safra Asset Management

Top funds holding Keros Therapeutics

BlackRock
BlackRock
Vanguard Group
Darwin Global Management
T. Rowe Price Associates
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Leucadia National Corporation
TCG Crossover Management
Holocene Advisors
Woodline Partners
Geode Capital Management
Citadel Advisors
Braidwell

View all funds holding Keros Therapeutics